Form 4 holding
EVP, Chief Financial Officer
Emergent BioSolutions Inc.
- Security class
- Common Stock
- Shares / value
- 374,083
- Estimated value
- $3,104,888
- Report date
- 08 Jun 2026
- Price
- $8.30
- Ownership
- Direct
Richard S. Lindahl - EVP, Chief Financial Officer at Emergent BioSolutions Inc.
Issuer-level insider activity
- Role
- EVP, Chief Financial Officer
- Issuer ticker
- EBS on NYSE
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Richard S. Lindahl since 04 Aug 2025
Reported holdings for Richard S. Lindahl in Emergent BioSolutions Inc.
Form 4 holding
EVP, Chief Financial Officer
Emergent BioSolutions Inc.
- Security class
- Employee Stock Option (Right to buy)
- Shares / value
- 557,346
- Estimated value
- Report date
- 03 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
EVP, Chief Financial Officer
Emergent BioSolutions Inc.
- Security class
- Employee Stock Options (Right to Buy)
- Shares / value
- 484,490
- Estimated value
- Report date
- 06 Mar 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Richard S. Lindahl in Emergent BioSolutions Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.